{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:03:01Z","timestamp":1746504181098,"version":"3.40.4"},"reference-count":22,"publisher":"ALUNA","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Aim: To evaluate plasma levels of TGF-\u03b21 and the clinical impact of platelet-rich plasma injections on mandibular opening and pain in patients with anterior disc displacement and intermittent locking.\nMaterials and Methods: Twenty-seven temporomandibular disorder patients, diagnosed by oral medicine specialists, received three intra-articular PRP injections over three months, with evaluations conducted two weeks after the final injection. Plasma TGF-\u03b21 levels were measured before and after treatment, with visual analog scale pain scores and mouth opening measurements.\nResults: Results showed that the mean plasma TGF-\u03b21 level in temporomandibular disorder patients increased significantly from (312.6 pg\/ml \u00b1 67.96) before PRP injection to (400.4 pg\/ml \u00b1 108.51) after PRP injection. Platelet-rich plasma-treated patients also experienced a significant reduction in Visual Analogue Scale scores, which decreased from (6.21 \u00b1 0.95) to (0.78 \u00b1 0.79), with improved range of mouth opening after PRP injection.\nConclusions: Intra-articular platelet-rich plasma injections effectively increased plasma TGF-\u03b21 levels, reduced pain intensity, and improved mandibular opening range in temporomandibular disorder patients.<\/jats:p>","DOI":"10.36740\/merkur202502101","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:48:07Z","timestamp":1746445687000},"page":"179-183","source":"Crossref","is-referenced-by-count":0,"title":["Estimation of plasma TGF-\u03b21 after intra-articular platelet rich plasma injection in-patient with anterior disc displacement with intermittent locking of TMJ disorder"],"prefix":"10.36740","volume":"53","author":[{"given":"Karar Abdulzahra","family":"Mahdi","sequence":"first","affiliation":[{"name":"DEPARTMENT OF ORAL PATHOLOGY, COLLEGE OF DENTISTRY, COLLEGE OF DENTISTRY, UNIVERSITY OF KUFA, NAJAF, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhassad H.","family":"Al-Mudhafar","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF ORAL PATHOLOGY, COLLEGE OF DENTISTRY, COLLEGE OF DENTISTRY, UNIVERSITY OF KUFA, NAJAF, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunya Malhan","family":"Hanweet","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF ORAL SURGERY, COLLEGE OF DENTISTRY, UNIVERSITY OF BABYLON, HILLA, BABYLON, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Zotti F, Albanese M, Rodella L, Nocini P. Platelet-Rich Plasma in Treatment of Temporomandibular Joint Dysfunctions: Narrative Review Int. J. Mol. Sci. 2019;20:277. doi: 10.3390\/ijms20020277.","DOI":"10.3390\/ijms20020277"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Koh K, Park H, Kim K. Relationship between anterior disc displacement with\/without reduction and effusion in temporomandibular disorder patients using magnetic resonance imaging Science in Dentistry. 2013;43:245-51. doi: 10.5624\/isd.2013.43.4.245.","DOI":"10.5624\/isd.2013.43.4.245"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Hassan F, Tarek M Ali, Nevein S. the clinical efficiency of platelet rich plasma in the treatment of temporomandibular joint disorders. Alexandria Dental Journal. 2016;41:226-231. doi: 10.21608\/adjalexu.2016.58021.","DOI":"10.21608\/adjalexu.2016.58021"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Loh JK, Lieu AS, Su YF. The alteration of plasma TGF-b1 levels in patients with brain tumors after tumor removal Kaohsiung journal of medical science. 2012;28:316-321. doi: 10.1016\/j.kjms.2011.11.012.","DOI":"10.1016\/j.kjms.2011.11.012"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Wilkes CH. Internal derangements of the temporomandibular joint. Pathological variations. Archives of Otolaryngology-Head & Neck Surgery. 1989;115:469-477. doi: 10.1001\/archotol.1989.01860280067019.","DOI":"10.1001\/archotol.1989.01860280067019"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Cantu R, Steffe J. Rehabilitation: for the post-surgical orthopedic patient. In Soft tissue healing considerations after surgery. 3rd ed. St Louis: Mosby. 2001.","DOI":"10.1016\/b978-0-323-07747-7.00002-2"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Lana JF, Weglein A, Vicente E et al. Platelet-rich Plasma: Regenerative Medicine: Sports Medicine, Orthopedic, and Recovery of Musculoskeletal Injuries. New York: Springer Science& Business. 2013. doi:10.1007\/978-3-642-40117-6.","DOI":"10.1007\/978-3-642-40117-6_9"},{"key":"ref7","unstructured":"8. Di Matteo B, Filardo G, Lo Presti M et al. Chronic antiplatelet therapy: a contraindication for Platelet Rich Plasma intraarticular injection. Eur Rev Med Pharmacol Sci. 2014;18(1):55-59."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Mazzocca AD, McCarthy MB, Chowaniec DM et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94(4):308-16. doi: 10.2106\/JBJS.K.00430.","DOI":"10.2106\/jbjs.k.00430"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Comert Kilic S, Gungormus M, Comert Kilic S, Gungormus M. Is Arthrocentesis Plus Platelet-Rich Plasma Superior to Arthrocentesis Alone in the Treatment of Temporomandibular Joint Osteoarthritis? A Randomized Clinical Trial. J. Oral Maxillofac. Surg. 2016;45:1538\u20131544. doi: 10.1016\/j.ijom.2016.06.009.","DOI":"10.1016\/j.ijom.2016.06.009"},{"key":"ref10","unstructured":"11. Barros V de M, Seraidarian PI, Cortes MI, de Paula LV. The impact of orofacial pain on the quality of life of patients with temporomandibular disorder. J Orofac Pain. 2009;23:28-37. doi: 10.11607\/ofph.23.1.07."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Cortese SG, Fridman DE, Farah CL et al. Frequency of oral habits, dysfunctions, and personality traits in bruxing and nonbruxing children: a comparative study. J Craniomand Pract. 2013;31:283-290. doi: 10.1179\/crn.2013.31.4.006.","DOI":"10.1179\/crn.2013.31.4.006"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Mazzetto MO, Lais CAR, Magri V et al. Severity of TMD Related to Age, Sex and Electromyographic Analysis. Braz Dent J. 2014;25(1):103-6440. doi: 10.1590\/0103-6440201302310.","DOI":"10.1590\/0103-6440201302310"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Slade GD, Bair E, Greenspan JD et al. Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study. J Pain. 2013;14:20-32. doi: 10.1016\/j.jpain.2013.07.014.","DOI":"10.1016\/j.jpain.2013.07.014"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Hanc\u0131 M, Karamese M, Tosun Z et al. Intra-articular platelet-rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis. J Craniomaxillofac Surg. 2015;43(1):162-6. doi: 10.1016\/j.jcms.2014.11.002.","DOI":"10.1016\/j.jcms.2014.11.002"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair and matrix biosynthesis. Arthritis Research & Therapy. 2014;16:204-19. doi: 10.1186\/ar4493.","DOI":"10.1186\/ar4493"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Mazzocca AD, Mc Carthy BR, Intravia J et al. An in vitro evaluation of the anti-inflammatory effects of platelet-rich plasma, ketorolac, and methyl prednisolone. J Arthroscopy. 2013;29:675-83. doi: 10.1016\/j.arthro.2012.12.005.","DOI":"10.1016\/j.arthro.2012.12.005"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Pihut M, Szuta M, Ferendiuk E et al. Evaluation of Pain Regression in Patients with Temporomandibular Dysfunction Treated by Intraarticular Platelet-Rich Plasma Injections: A Preliminary Report. Biomed Res Int. 2014;2014:132369. doi: 10.1155\/2014\/132369.","DOI":"10.1155\/2014\/132369"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Bauge C, Girard N, Leclercq S et al. Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocyte. Biochim Biophys Acta. 2012;1823:983-986. doi: 10.1016\/j.bbamcr.2012.02.017.","DOI":"10.1016\/j.bbamcr.2012.02.017"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20. Sharma SM, Thakar D. the clinical efficacy of autologous concentrated platelets in treatment of tmj disorders - a pilot study Nitte University Journal of Health Science. NUJHS. 2014;4(3). doi:10.1055\/s-0040-1703805.","DOI":"10.1055\/s-0040-1703805"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Manafikhi M, Ataya J, Heshmeh O. Evaluation of the efficacy of platelet rich fibrin (I-PRF) intra-articular injections in the management of internal derangements of temporomandibular joints - a controlled preliminary prospective clinical study. BMC Musculoskelet Disord. 2022;23(1):454. doi:10.1186\/s12891-022-05421-7.","DOI":"10.1186\/s12891-022-05421-7"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Zheng L, Pi C, Zhang J et al. Aberrant activation of latent transforming growth factor-\u03b2 initiates the onset of temporomandibular joint osteoarthritis. Bone Research. 2018;6:26. doi: 10.1038\/s41413-018-0027-6.","DOI":"10.1038\/s41413-018-0027-6"}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:48:11Z","timestamp":1746445691000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek2025i2net.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202502101","archive":["Internet Archive"],"relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}